JP Morgan Chase’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.54M Sell
263,091
-7,735
-3% -$185K ﹤0.01% 3233
2025
Q4
$7.23M Sell
270,826
-55,095
-17% -$1.32M ﹤0.01% 2988
2025
Q3
$6.96M Buy
325,921
+13,984
+4% +$331K ﹤0.01% 3067
2025
Q2
$6.73M Sell
311,937
-12,788
-4% -$238K ﹤0.01% 2886
2025
Q1
$5.39M Sell
324,725
-388,635
-54% -$7.06M ﹤0.01% 3100
2024
Q4
$13.1M Buy
713,360
+272,236
+62% +$4.39M ﹤0.01% 2446
2024
Q3
$6.78M Sell
441,124
-187,125
-30% -$3.12M ﹤0.01% 2966
2024
Q2
$10.2M Buy
628,249
+153,245
+32% +$2.47M ﹤0.01% 2455
2024
Q1
$8.78M Sell
475,004
-185,896
-28% -$4.61M ﹤0.01% 2601
2023
Q4
$20.7M Buy
660,900
+202,985
+44% +$4.85M ﹤0.01% 1826
2023
Q3
$9.54M Buy
457,915
+176,923
+63% +$4.81M ﹤0.01% 2286
2023
Q2
$6.73M Sell
280,992
-1,303,792
-82% -$29M ﹤0.01% 2636
2023
Q1
$29.8M Sell
1,584,784
-510,707
-24% -$9.73M ﹤0.01% 1369
2022
Q4
$33.4M Buy
2,095,491
+236,530
+13% +$3.7M ﹤0.01% 1327
2022
Q3
$30.4M Sell
1,858,961
-47,759
-3% -$773K ﹤0.01% 1307
2022
Q2
$26.9M Sell
1,906,720
-403,635
-17% -$7.53M ﹤0.01% 1398
2022
Q1
$56M Buy
2,310,355
+108,179
+5% +$2.62M 0.01% 1105
2021
Q4
$51.4M Sell
2,202,176
-113,440
-5% -$2.28M 0.01% 1200
2021
Q3
$38.5M Sell
2,315,616
-65,952
-3% -$1.27M 0.01% 1319
2021
Q2
$58.1M Buy
2,381,568
+979,855
+70% +$22.1M 0.01% 1146
2021
Q1
$36.2M Buy
1,401,713
+459,903
+49% +$20.2M 0.01% 1319
2020
Q4
$50.3M Buy
941,810
+71,968
+8% +$3.57M 0.01% 1066
2020
Q3
$35.1M Sell
869,842
-206,713
-19% -$8.93M 0.01% 1159
2020
Q2
$52.2M Sell
1,076,555
-20,751
-2% -$996K 0.01% 869
2020
Q1
$46.4M Sell
1,097,306
-24,910
-2% -$1.03M 0.01% 836
2019
Q4
$48M Buy
1,122,216
+25,090
+2% +$1.09M 0.01% 986
2019
Q3
$39.5M Sell
1,097,126
-77,637
-7% -$2.35M 0.01% 1072
2019
Q2
$31.1M Buy
1,174,763
+367,547
+46% +$9.39M 0.01% 1257
2019
Q1
$21.7M Sell
807,216
-13,955
-2% -$326K ﹤0.01% 1489
2018
Q4
$13.3M Buy
821,171
+10,184
+1% +$198K ﹤0.01% 1787
2018
Q3
$16.8M Buy
810,987
+312,648
+63% +$4.92M ﹤0.01% 1801
2018
Q2
$7.61M Sell
498,339
-1,429,257
-74% -$25.5M ﹤0.01% 2360
2018
Q1
$43.3M Sell
1,927,596
-11,784
-0.6% -$326K 0.01% 1018
2017
Q4
$58.4M Buy
1,939,380
+59,556
+3% +$1.9M 0.01% 905
2017
Q3
$72.1M Sell
1,879,824
-3,342
-0.2% -$109K 0.02% 755
2017
Q2
$52.5M Buy
1,883,166
+96,742
+5% +$2.88M 0.01% 884
2017
Q1
$61.4M Sell
1,786,424
-273,408
-13% -$9.65M 0.02% 840
2016
Q4
$59.4M Buy
2,059,832
+505,213
+32% +$13.4M 0.02% 801
2016
Q3
$49.5M Buy
1,554,619
+657,771
+73% +$22.3M 0.01% 843
2016
Q2
$29.1M Sell
896,848
-137,474
-13% -$4.6M 0.01% 1145
2016
Q1
$28.9M Buy
1,034,322
+24,986
+2% +$545K 0.01% 1098
2015
Q4
$36M Sell
1,009,336
-6,813
-0.7% -$240K 0.01% 972
2015
Q3
$33.6M Sell
1,016,149
-139,095
-12% -$5.79M 0.01% 972
2015
Q2
$48.4M Sell
1,155,244
-204,444
-15% -$7.91M 0.01% 889
2015
Q1
$44.3M Sell
1,359,688
-135,209
-9% -$4.65M 0.01% 954
2014
Q4
$47.5M Buy
1,494,897
+537,419
+56% +$15.2M 0.01% 954
2014
Q3
$23.7M Buy
957,478
+7,669
+0.8% +$179K 0.01% 1328
2014
Q2
$21.5M Buy
949,809
+107,952
+13% +$2.25M 0.01% 1302
2014
Q1
$20.5M Buy
841,857
+21,658
+3% +$548K 0.01% 1298
2013
Q4
$20.5M Sell
820,199
-71,998
-8% -$1.7M 0.01% 1316
2013
Q3
$24.5M Buy
892,197
+4,665
+0.5% +$97.5K 0.01% 1195
2013
Q2
$16.1M Buy
+887,532
New +$12.2M 0.01% 1382

Other funds holding ACAD